Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:1072-1079
Published online before print March 31, 2003, doi: 10.1161/01.HYP.0000066289.17754.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/5/1072    most recent
01.HYP.0000066289.17754.49v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M.
Related Collections
Right arrow Obesity

(Hypertension. 2003;41:1072.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Interactions Between Leptin and the Human Sympathetic Nervous System

Nina Eikelis; Markus Schlaich; Anuradha Aggarwal; David Kaye; Murray Esler

From the Baker Heart Research Institute and Alfred Baker Medical Unit, Alfred Hospital, Melbourne, Australia.

Correspondence to Prof Murray Esler, Baker Heart Research Institute, PO Box 6492 St Kilda Rd Central, Melbourne, Victoria 8008, Australia. E-mail murray.esler{at}baker.edu.au

Results from animal experimentation suggest a 2-way interaction between leptin and the sympathetic nervous system, with leptin causing sympathetic activation and conversely, with the sympathetic system exercising regulatory feedback inhibition over leptin release. We have now tested this hypothesis in humans. In the absence of results from leptin infusions, to test for sympathetic stimulation of leptin release, we sought a quantitative naturalistic linkage of sympathetic activity with leptin plasma concentration across a broad range of leptin values in men of widely differing adiposity. Renal norepinephrine spillover was correlated with plasma leptin (r=0.628, P<0.01), but other measures of sympathoadrenal function did not. To test for sympathetic and adrenomedullary inhibition of leptin release, we studied clinical models of high sympathetic tone, heart failure, and essential hypertension, in which lowered plasma leptin levels might have been expected but were not found; a model of low sympathetic activity, pure autonomic failure, in which plasma leptin level was normal (6.1±1.2 vs 12.8±3.1 ng/mL in healthy subjects); and a clinical model of reduced epinephrine secretion, healthy aging, in which plasma leptin level again was normal (5.7±1.1 ng/mL vs 4.0±0.9 ng/mL in men >60 years and <35 years, respectively). Paradoxically, leptin concentration was elevated in heart failure, caused entirely by reduced renal clearance of leptin release, 142.0±30.5 mL/min, compared with 56.9±18.9 mL/min (P<0.05). These results provide some support for the view that leptin stimulates the sympathetic nervous system, at least for renal sympathetic outflow, but do not confirm the concept of regulatory feedback inhibition of leptin release by the sympathetic nervous system.


Key Words: leptin • nervous system, sympathetic renal • heart failure • hypertension, essential • autonomic nervous system • aging • obesity




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
A. R. Kristal, K. B. Arnold, J. M. Schenk, M. L. Neuhouser, P. Goodman, D. F. Penson, and I. M. Thompson
Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial
Am. J. Epidemiol., April 15, 2008; 167(8): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert
Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension
Hypertension, November 1, 2007; 50(5): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Katagiri, T. Yamada, and Y. Oka
Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals
Circ. Res., July 6, 2007; 101(1): 27 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Diepvens, K. R. Westerterp, and M. S. Westerterp-Plantenga
Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R77 - R85.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Esler, N. Straznicky, N. Eikelis, K. Masuo, G. Lambert, and E. Lambert
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Hypertension, November 1, 2006; 48(5): 787 - 796.
[Full Text] [PDF]


Home page
DiabetesHome page
J. Janke, S. Engeli, M. Boschmann, F. Adams, J. Bohnke, F. C. Luft, A. M. Sharma, and J. Jordan
Retinol-binding protein 4 in human obesity.
Diabetes, October 1, 2006; 55(10): 2805 - 2810.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Esler and N. Eikelis
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity?
J Appl Physiol, January 1, 2006; 100(1): 11 - 12.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. E. Straznicky, E. A. Lambert, G. W. Lambert, K. Masuo, M. D. Esler, and P. J. Nestel
Effects of Dietary Weight Loss on Sympathetic Activity and Cardiac Risk Factors Associated with the Metabolic Syndrome
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5998 - 6005.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
N. Eikelis and M. Esler
The neurobiology of human obesity
Exp Physiol, September 1, 2005; 90(5): 673 - 682.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, A. Facchini, F. Q. Trevano, R. Dell'Oro, F. Arenare, F. Tana, G. Bolla, A. Monzani, M. Robuschi, and G. Mancia
Obstructive Sleep Apnea-Dependent and -Independent Adrenergic Activation in Obesity
Hypertension, August 1, 2005; 46(2): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Rahmouni, D. A. Morgan, G. M. Morgan, A. L. Mark, and W. G. Haynes
Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension
Diabetes, July 1, 2005; 54(7): 2012 - 2018.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark
Obesity-Associated Hypertension: New Insights Into Mechanisms
Hypertension, January 1, 2005; 45(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Eikelis, G. Lambert, G. Wiesner, D. Kaye, M. Schlaich, M. Morris, J. Hastings, F. Socratous, and M. Esler
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E744 - E752.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. F. DiBona
The Sympathetic Nervous System and Hypertension: Recent Developments
Hypertension, February 1, 2004; 43(2): 147 - 150.
[Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
K. Rahmouni and W. G. Haynes
Leptin and the Cardiovascular System
Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244.
[Abstract] [Full Text]